Female hormone therapy associated with risk of intracranial hemorrhage in patients with cerebral spongiform malformations

Published Date: 04 Mar 2023

Germany: A recent study shows that female hormone therapy increases the risk of cerebral hemorrhage in patients with cerebral hemorrhage.

Read Full News

Latest News

Medical Bulletin 09/December 2023.

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

To advance space and high altitude medicine, AIIMS Delhi and AFMS collaborate.

New Delhi: A memorandum of understanding (MOU) will be signed by the Directorate General of the All India Institute of Medical Sciences (AIIMS) in New Delhi.

A study found that elderly people with poorer diet quality may benefit cognitively from taking a cocoa extract supplement.

USA: A new study on the impact of supplementing with cocoa extract on cognition was published in The American Journal of Clinical Nutrition.

Delhi High Court criticizes the Delhi Medical Council, asserting that the public has a right to know whether or not a person identifying themselves as an MD is in fact in possession of that degree.

New Delhi: In contemplation of filing a Public Interest Litigation (PIL) to obtain a deadline-bound verification of medical and educational credentials.

A strange link between owning cats and schizophrenia has been found in a study.

Cats are wonderful pets, and they can be enjoyed in both large and small homes. However, a recent review indicates that owning a cat may not be the best idea.

In the Philippines, relief for FMGs: NMC grants course recognition to students who were enrolled in BS courses prior to the implementation of FMGL regulations.

The declaration by the National Medical Commission (NMC) that students who were foreign medical students in the Philippines are truly relieved.

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Assaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

Results from the EVOKE and EVOKE+ phase 3 studies reported that oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer disease.

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

The FDA has approved Novartis’ intrathecal formulation of onasemnogene abeparvovec-brve, marketed as Itvisma, for patients ages 2 years and older living with spinal muscular atrophy.

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Findings revealed that vitamin D deficiency was associated with an increased risk of NMOSD in East Asian populations, whereas the effect of smoking among Caucasians and other populations was inconsistent.

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Doug Kerr, MD, PhD, chief medical officer at Dyne Therapeutics, discusses the clinical development of DYNE-101 for myotonic dystrophy type 1 and DYNE-251 for Duchenne muscular dystrophy.

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Assaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

Results from the EVOKE and EVOKE+ phase 3 studies reported that oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer disease.

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

The FDA has approved Novartis’ intrathecal formulation of onasemnogene abeparvovec-brve, marketed as Itvisma, for patients ages 2 years and older living with spinal muscular atrophy.

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Findings revealed that vitamin D deficiency was associated with an increased risk of NMOSD in East Asian populations, whereas the effect of smoking among Caucasians and other populations was inconsistent.

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Doug Kerr, MD, PhD, chief medical officer at Dyne Therapeutics, discusses the clinical development of DYNE-101 for myotonic dystrophy type 1 and DYNE-251 for Duchenne muscular dystrophy.

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

Latest News

The most important medical news of the day is as follows: early age at first menstrual cycle associated with increased risk of diabetes in middle age.

New Delhi: A memorandum of understanding (MOU) will be signed by the Directorate General of the All India Institute of Medical Sciences (AIIMS) in New Delhi.

USA: A new study on the impact of supplementing with cocoa extract on cognition was published in The American Journal of Clinical Nutrition.

New Delhi: In contemplation of filing a Public Interest Litigation (PIL) to obtain a deadline-bound verification of medical and educational credentials.

Cats are wonderful pets, and they can be enjoyed in both large and small homes. However, a recent review indicates that owning a cat may not be the best idea.

The declaration by the National Medical Commission (NMC) that students who were foreign medical students in the Philippines are truly relieved.

News All Time

Delhi High Court: MCI sanctions cannot be used as a yardstick for determining a doctor's shortcomings, flaws, or insufficiency.

New Delhi: The Delhi High Court recently declared that the punishment awarded by the MCI, which is now the National Medical Commission (NMC), could not be an.

Eugene A. Woods joins the board of directors at JnJ.

Johnson and Johnson has announced in New Brunswick that Eugene A. The new CEO of Advocate Health is Woods, MBA, MHA.

As per JAMA, Prone Positioning Has No Effect on the Length of ECMO Weaning in Covid Patients with Severe ARDS.

According to Matthieu Schmidt and colleagues, a randomized clinical trial examined the effects of prone positioning on patients suffering from severe acute respiratory distress.

Rituximab and glucocorticoids in Wegener's Granulomatosis: A PMS Study Report approved by the CDSCO Panel.

New Delhi: The Central Drug Standard Control Organization (CDSCO)'s Subject Expert Committee (SEC) has authorized a post-marketing.

The manufacture and marketing of Azelnidipine and Metoprolol FDC tablets has been approved by the CDSCO Panel for Akum Pharmaceutical.

New Delhi: The Subject Expert Committee (SEC) operating under the Central Drug Standard has given the go-ahead to the pharmaceutical giant Akum Pharmaceuticals.

A radiologist found guilty of violating the PC PNDT Act received a two-year rigorous prison sentence.

A session court in Jabalpur has found a DMRD doctor guilty of a heinous violation of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act.

The deadline to submit course preferences, willingness to work, and fee for the special straw vacancy round for PG medical seats in Puducherry is today.

The Centralized Admission Committee (CENTAC) in Puducherry has released a notification concerning the special stray vacancy round for three open NEET PG seats.

Check Your Information: Media reports asserting that biology is not necessary for NEET UG are false.

New Delhi: Posts on social media assert that biology coursework is no longer necessary for applicants to the National Exam to pursue careers in medicine.

The MP government issues a directive to Yatharth Hospital to assume control of the Ramraja Hospital grounds.

MP: As a result of an order from the Commissionerate of Sagar Sambhag, Madhya, Yatharth Hospital experienced significant trouble yesterday.

Health Bulletin / November 30, 2023.

Following a spike in respiratory cases, Uttarakhand and Karnataka are on alert due to a pneumonia outbreak in China. These are the top health stories of the day.

No Medical Negligence: Kerala High Court Rejects Payment to Patient Who Delivered Fifth Child Despite Post-Partum Sterilization.

In Ernakulam, a 39-year-old woman who underwent family planning was denied compensation after becoming pregnant and giving birth to her fifth child.

When open-angle glaucoma is first diagnosed, abstinence from alcohol lessens the severity of vision impairment.

High intraocular pressure and a greater incidence of open-angle glaucoma (OAG) have been associated with alcohol consumption. More research is still needed.

When compared to standard strategies, the use of MRI-guided biopsy for prostate cancer surveillance is more cost-effective.

Compared to conventional methods, MRI use and possibly MRI-guided biopsy are more affordable for prostate cancer surveillance.

Provide Justification for Research on Tocilizumab in Patients with Giant Cell Arteritis: Cipla Hears from the CDSCO Panel.

Examining the procedure that the pharmaceutical company Cipla submitted for the approval of post-marketing active surveillance of tocilizumab in patients in New Delhi.

A study found that steroid therapy combined with hyperbaric oxygen therapy was effective for individuals experiencing sudden hearing loss.

Japan: A recent study that was published in Otology and Neurotology found that using hyperbaric oxygen therapy in conjunction with other treatments improved recovery rates.

Which is better for treating pain following surgery in young patients: NSAIDs or opioids?

USA: To find out, a recent study compared two treatment plans: one that included a low-dose opioid addition and the other that used a regimen of non-opioid medication.

Recommended News For You

Is Exercise an Effective Treatment for Prostate Cancer?

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

November 2023, Medical Bulletin 04/.

Early, virtual palliative care feasible for advanced lung cancer

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

Recommended Articles For You

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Sorafenib: Understanding the science behind a powerful cancer drug  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-associated cancers may be on the rise in Puerto Rico

2.

Study finds 81% of cancer cures touted by TikTok videos are fake

3.

Novel Agent for Chronic GVHD Wins FDA Approval

4.

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries

5.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

1.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

2.

Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology

3.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

4.

What Is A High MCV Level? Causes, Symptoms, And Treatment Options

5.

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Navigating the Complexities of Ph Negative ALL - Part V

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot